Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Firebrick Pharma Limited ( (AU:FRE) ) has provided an update.
Firebrick Pharma Limited has announced a change in the interests of a substantial holder, Stephen Francis Goodall and related parties. The change, effective from March 5, 2025, reflects a dilutionary effect due to a private placement, resulting in an adjusted voting power. This development may impact the company’s shareholder structure and influence its governance dynamics.
More about Firebrick Pharma Limited
YTD Price Performance: 53.33%
Average Trading Volume: 178,145
Technical Sentiment Consensus Rating: Sell
Find detailed analytics on FRE stock on TipRanks’ Stock Analysis page.